Selected Grants
The Genetic Base of Bone Disease in Mycobacterial Infection
ResearchCo Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2023 - 2028Innate Immune Determinants of Granuloma Formation in the Zebrafish
ResearchCo Investigator · Awarded by National Institutes of Health · 2017 - 2027Genetic Dissection of Angiogenesis in the Tuberculous Granuloma
ResearchCo Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2022 - 2027Linking human TB genetic susceptibility loci to granuloma biology
ResearchCo Investigator · Awarded by National Institutes of Health · 2022 - 2026Combined Use of Statistical Process Control and Whole Genome Sequencing to Detect and Investigate Nontuberculous Mycobacterial Clusters and Outbreaks (K08)
ResearchCo-Mentor · Awarded by National Institute of Allergy and Infectious Diseases · 2021 - 2026Interdisciplinary Research Training Program in AIDS
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2010 - 2025MACrO2
Clinical TrialPrincipal Investigator · Awarded by AN2 Therapeutics · 2022 - 2025Epidemiology/General Communicable Disease Control - Tuberculosis (TB) Elimination
Public ServicePrincipal Investigator · Awarded by NC DHHS · 2024 - 2024Epidemiology/General Communicable Disease Control
Public ServicePrincipal Investigator · Awarded by NC DHHS · 2022 - 2022Tuberculosis Trial Consortium
Clinical TrialPrincipal Investigator · Awarded by Washington DC VA Medical Center · 2020 - 2021Prospective Comparison of the Tuberculin Skin Test (TST) vs. Interferon Gamma Release Assays (IGRAs) in Diagnosing Latent Tuberculosis Infection (LTBI) and in Predicting Progression fro LTBI to Active Tuberculosis Disease
ResearchPrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2011 - 2021Prospective Comparison of the Tuberculin Skin Test (TST) vs. Interferon Gamma Release Assays (IGRAs) in Diagnosing Latent Tuberculosis Infection (LTBI) and in Predicting Progression from LTBI to Active Tuberculosis Disease
ResearchPrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2011 - 2021Tuberculosis Trial Consortium
Clinical TrialPrincipal Investigator · Awarded by FHI 360 · 2019 - 2020Epidemiology/General Communicable Disease Control
Public ServicePrincipal Investigator · Awarded by NC Department of Health and Human Services · 2019 - 2019Epidemiology/General Communicable Disease Control
Public ServicePrincipal Investigator · Awarded by NC Department of Health and Human Services · 2018 - 2018Epidemiology/General Communicable Disease Control
Public ServicePrincipal Investigator · Awarded by NC Department of Health and Human Services · 2017 - 2017The Genetic Basis of Bone Disease in Mycobacterial Infection
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2014 - 2017Role of Developmental Signaling Pathways in Tuberculosis Pathogenesis
FellowshipCollaborating Investigator · Awarded by National Institutes of Health · 2017 - 2017Tuberculosis Trial Consortium
Clinical TrialPrincipal Investigator · Awarded by Family Health International · 2009 - 2014Mathematical Modeling in Clinical Trials of Tuberculosis Therapeutics
ResearchMentor · Awarded by National Institutes of Health · 2009 - 2014Large Scale Antibody and TCell Epitope Discovery
ResearchConsultant · Awarded by National Institutes of Health · 2004 - 2011Role of non-tuberculous mycobacteria in lung disease
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2003 - 2008External Relationships
- Up To Date Inc/Wolters Kluwer Health
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.